Influence of recency and duration of glucocorticoid use on bone mineral density and risk of fractures: population-based cohort study

Heart Failure Is a Clinically and Densitometrically Independent Risk Factor for Osteoporotic Fractures: Population-Based Cohort Study of 45,509 Subjects

(2012) Sumit R. Majumdar et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Population-Based Trends in Osteoporosis Management after New Initiations of Long-Term Systemic Glucocorticoids (1998–2008)

(2012) S. R. Majumdar et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis

(2012) S. Lekamwasam et al.   OSTEOPOROSIS INTERNATIONAL

Glucocorticoid-Induced Bone Disease

(2011) Robert S. Weinstein   NEW ENGLAND JOURNAL OF MEDICINE

Guidance for the adjustment of FRAX according to the dose of glucocorticoids

(2011) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

FRAX® and its applications to clinical practice

(2009) John A. Kanis et al.   BONE

Proton-Pump Inhibitor Use Is Not Associated With Osteoporosis or Accelerated Bone Mineral Density Loss

(2009) Laura E. Targownik et al.   GASTROENTEROLOGY